ALS Limited
CPBLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7 | $6 | $6 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $1 | $1 |
| Enterprise Value | $9 | $7 | $7 | $7 |
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 21.8% | 8% | 8.1% | – |
| Gross Profit | $3 | $2 | $2 | $2 |
| % Margin | 89.8% | 89.2% | 88.9% | 89.2% |
| EBITDA | $1 | $0 | $1 | $0 |
| % Margin | 20.5% | 14.4% | 25.7% | 22.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.5% | 0.5% | 12.8% | 9% |
| EPS Diluted | 0.53 | 0.027 | 0.6 | 0.39 |
| % Growth | 1,900% | -95.6% | 53.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |